Anti-TNF immunotherapy reduces CD8+ T cell–mediated antimicrobial activity against Mycobacterium tuberculosis in humans-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-TNF immunotherapy reduces CD8+ T cell–mediated antimicrobial activity against Mycobacterium tuberculosis in humans

Published:2009-05-01 Issue:5 Volume:119 Page:1167-1177
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Bruns Heiko,Meinken Christoph,Schauenberg Philipp,Härter Georg,Kern Peter,Modlin Robert L.,Antoni Christian,Stenger Steffen

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference85 articles.

1. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy

2. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

3. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

4. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics

5. Tumor Necrosis Factor Inhibitors for Rheumatoid Arthritis

Cited by 258 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial Transplantation Promotes Protective Effector and Memory CD4⁺ T Cell Response During Mycobacterium Tuberculosis Infection and Diminishes Exhaustion and Senescence in Elderly CD4⁺ T cells;Advanced Science;2024-07-22

2. Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli;2024-01-31

3. Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination;BMC Immunology;2023-11-30

4. Protecting the most vulnerable: tuberculosis in immunocompromised individuals;The Challenge of Tuberculosis in the 21st Century;2023-09-01

5. Tacrolimus After rATG and Infliximab Induction Immunosuppression—RIMINI Trial;Transplantation;2023-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3